UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000048760
Receipt number R000055549
Scientific Title Phase II trial of preoperative chemoradiotherapy using intensity-modulated radiotherapy for locally advanced rectal cancer
Date of disclosure of the study information 2022/08/26
Last modified on 2023/02/25 13:57:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II trial of preoperative chemoradiotherapy using intensity-modulated radiotherapy for locally advanced rectal cancer

Acronym

Phase II trial of preoperative chemoradiotherapy using intensity-modulated radiotherapy for locally advanced rectal cancer

Scientific Title

Phase II trial of preoperative chemoradiotherapy using intensity-modulated radiotherapy for locally advanced rectal cancer

Scientific Title:Acronym

Phase II trial of preoperative chemoradiotherapy using intensity-modulated radiotherapy for locally advanced rectal cancer

Region

Japan


Condition

Condition

Locally advanced rectal cancer

Classification by specialty

Gastroenterology Hematology and clinical oncology Gastrointestinal surgery
Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To explore whether IMRT reduces the acute grade 2 diarrhea in preoperative chemoradiotherapy for locally advanced rectal cancer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Grade 2 Acute diarrhea

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Intensity-modulated radiotherapy (1.8 Gy/fr, 45-50.4Gy), Capecitabine 1650 mg/m2/day oral administration on the day of radiotherapy.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Histologically confirmed rectal adenocarcinoma
2) Following three criteria was met,
i) Palpable by digital examination or within 12 cm from anal verge
ii) Positive circumferential resection margin or clinical T3-4N0 or T1-4N1-2
iii) No peritoneal, hepatic and lung metastasis
3) >=20 years old
4) Performance Status 0-2
5) No history of pelvic radiotherapy
6) Adequate organ function
Neutrophil count >= 1500/mm3
Platelet count >=100 000/mm3
Total bilirubin <=1.5 ULN
Both serum aspartate aminotransferase and alanine aminotransferase <=100 IU/L
CCr >= 30 ml/min/body
7) Able to intake orally
8) Grade 0-1 diarrhea
9) Written consent to participate in the current trial

Key exclusion criteria

1) Uncontrollable comorbidity (diarrhea, interstitial pneumonia, collagen vascular disease,diabetes mellitus, heart failure etc)
2) Pregnant or child-bearing potential, lactating patients
3) History of hypersensitivity to capecitabine or 5-fluorouracil
4) Currently taking tegafur/Gimeracil/Oteracil or within 7 days after discontinuation
5) Considered to be difficult to participate the current trial from psychotic disorders

Target sample size

55


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Mizowaki

Organization

Kyoto University Graduate School and Faculty of Medicine

Division name

Department of Radiation Oncology and Image-applied Therapy

Zip code

6068507

Address

54, Shogoinn, Sakyo-ku,Kyoto, Kyoto

TEL

0757513762

Email

mizo@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Katsuyuki
Middle name
Last name Sakanaka

Organization

Kyoto University Graduate School and Faculty of Medicine

Division name

Department of Radiation Oncology and Image-applied Therapy

Zip code

6068507

Address

54, Shogoinn, Sakyo-ku,Kyoto, Kyoto

TEL

0757513762

Homepage URL


Email

sakanaka@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 08 Month 25 Day

Date of IRB

2022 Year 10 Month 17 Day

Anticipated trial start date

2022 Year 10 Month 25 Day

Last follow-up date

2026 Year 04 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 08 Month 25 Day

Last modified on

2023 Year 02 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055549


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name